GenCure announces breakthrough first run of 80-liter bioreactor

August 13, 2019 Biomanufacturing CDMO among first to harvest adult stem cells at large scale In a breakthrough for the regenerative medicine industry, GenCure announced today that its biomanufacturing services team has successfully completed production runs expanding and harvesting human mesenchymal stem cells (hMSCs) in an 80-liter bioreactor. GenCure, a subsidiary of BioBridge Global (BBG), […]

Read More